Skip to main navigation
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Patients
Investors
News
Careers
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Patients
Investors
News
Careers
Main Menu
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Patients
Investors
News
Careers
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Patients
Investors
News
Careers
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Patients
Investors
News
Careers
Main Menu
About Us
Team
Programs and Pipeline
Menu Toggle
Summary and Pipeline
Orexin Receptor 2 Agonist Program
LockBody® Technology Platform
Patients
Investors
News
Careers
Overview
Press Releases
Events & Presentations
Financials
SEC Filings
Annual Reports
Stock Info
Stock Quote & Chart
Historical Price Lookup
Analyst Coverage
Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Annual General Meeting
Shareholder Resources
FAQs
Email Alerts
Contact Us
RSS Feeds
PFIC Information
Event Details
Oppenheimer Sleep Disorders Summit
Dec 1, 2023
Fireside chat
Click here for Webcast
Print Page
FAQs
Email Alerts
Contact Us
RSS Feeds
